Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme

AIMS/HYPOTHESIS: Approximately 10% of total healthcare budgets worldwide are spent on treating diabetes and its complications, and budgets are increasing globally because of ageing populations and more expensive second-line medications. The aims of the study were to estimate the within-trial and lif...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Diabetologia
Hoofdauteurs: Xin, Yiqiao, Davies, Andrew, Briggs, Andrew, McCombie, Louise, Messow, C. Martina, Grieve, Eleanor, Leslie, Wilma S., Taylor, Roy, Lean, Michael E. J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer Berlin Heidelberg 2020
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7476973/
https://ncbi.nlm.nih.gov/pubmed/32776237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-020-05224-2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items